High-dose polychemotherapy of patients with poor-prognosis anaplastic T.0-large cell ALK+ lymphosarcoma

High-dose polychemotherapy of patients with poor-prognosis anaplastic T.0-large cell ALK+ lymphosarcoma

Aim. To evaluate efficacy of the protocol NHL BFM-90 in the treatment of adult anaplastic large cell lymphosarcoma (ALCL) ALK+ and validity of addition of transplantation of autologous stem hemopoietic cells (ASHC) into first line treatment. Material and methods. We treated 13 patients with stage II...

Full description

Bibliographic Details
Main Authors: Lidiya Gamilevna Aitova, Yuliya Eykhenovna Vinogradova, Irina Borisovna Kaplanskaya, Irina Nikolaevna Lutsenko, Evgeniy Evgen'evich Zvonkov, Kira Sergeevna Momotyuk, Sergey Kirillovich Kravchenko, Aleksandra Mikhaylovna Kremenetskaya, Andrey Ivanovich Vorob'ev, L G Aitova, Yu E Vinogradova, I B Kaplanskaya, I N Lutsenko, E E Zvonkov, K S Momotyuk, S K Kravchenko, A M Kremenetskaya, A I Vorobyev
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2009-07-01
Series:Терапевтический архив
Subjects:
nhl-bfm-90
anaplastic alk+ lymphosarcoma
nhl bfm-90
transplantation of autologous stem cells of blood
factors of poor prognosis
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30393

Similar Items

Similar Items